Insightec
PrivateLast Round
IPO
Oct 1, 2025
Est. Valuation
$375M
Total Funding Raised
$966.65M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Insightec is a medical technology company that develops and commercializes MRI-guided focused ultrasound devices for non-invasive treatments of various oncology and neurology conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Insightec Comparables
Compare Insightec with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chongqing Haifu Medical Technology Co., Ltd. | 78% | |
| HistoSonics | 78% | |
| Image Guided Therapy | 78% |
Insightec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Oct 1, 2025 | ||||
| Series G | Jun 18, 2024 | ||||
| Debt | Sep 1, 2022 | ||||
| Series F | Mar 6, 2020 | ||||
| Series E | Jan 31, 2018 | ||||
Series E | Dec 14, 2017 |
Key People
Founding team and executive leadership
Insightec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series G, Debt |
| MedTech Advisors | Convertible Debt, Series E, Series C, Series B, Series D Extension, Series D |
| GE Capital | Series B |
| Ally Bridge Group | Series G |
| York Capital Management | Series G, Series E, Series D, Series D Extension |
| Gilmartin Capital | Series G |
| Nexus NeuroTech Ventures | Series G |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Job posting reveals a strategic alliance with CRL as part of its core portfolio.
- May 11, 2026
Partnered with LOTUS Neuro as part of core portfolio.
Insightec Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Insightec's valuation, stock price, and market status.
Is Insightec a public or private company?
Insightec is a private company.
What is the current stock price of Insightec?
Insightec is a private company, so its shares have no public market price. Caplight tracks Insightec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Insightec worth (valuation)?
Insightec's valuation is estimated at $375.0M based on funding round data.
Can I buy Insightec stock?
Insightec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Insightec's last funding round?
Insightec's most recent funding round was IPO on October 1, 2025.
Who are the main investors in Insightec?
Key investors in Insightec include MedTech Advisors, Ally Bridge Group, York Capital Management, Nexus NeuroTech Ventures, Fidelity Management & Research Company.
Will Insightec IPO soon?
No public IPO plans have been announced for Insightec.
How can I track Insightec secondary market activity?
Caplight tracks bids, offers, and trades in Insightec's shares on secondary markets.